pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
AG120-C-001
Phase 1 · other · AG-120 is being investigated for the treatment of patients with advanced hematologic malignancies that are IDH1 mutation.
AG120-C-001 for AG-120 is being investigated for the treatment of patients with advanced hematologic malignancies that are IDH1 mutation. is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).
Internal code AG120-C-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Phase 1
- Modality
- other
- Indication
- AG-120 is being investigated for the treatment of patients with advanced hematologic malignancies that are IDH1 mutation.
- Status
- active
- Trials
- 1